Could a diabetes drug slow down type 1 diabetes before it starts?
NCT ID NCT07430332
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether semaglutide, a drug already used for type 2 diabetes, can protect the body's insulin-producing cells in people with stage 1 type 1 diabetes. The goal is to see if it can delay or prevent the disease from progressing to the next stage. Fifteen adults will receive either semaglutide or a placebo, and researchers will measure hormone responses over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE 1 DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••